CORE: Outreach and Recruitment (Core E) PI Name: Jason Karlawish Project Summary/Abstract The goal of the Penn ADCC Outreach and Recruitment (OR) Core (Core E) is to advance research and to develop the public's understanding of what is AD, and how to live with it. We achieve our goal through the mission of educating and empowering the Philadelphia region and the nation; collaborating with the Clinical, Data, and Neuropathology, Genetics and Biomarker Cores to recruit and retain research participants, and, in this new cycle, we are excited about innovative plans to collaborate with the Research Education Component (Core F) and Administrative Core to train the next generation of researchers. Our regional efforts to educate and empower have a focus on Philadelphia's African-American community. Our approach recognizes that we work in an aging state and in a diverse community, and that our task is to change behavior, such as persuading an older adult to join a study, or a clinician to adopt a new method to assess cognition. Successful behavior change requires not simply presenting information but innovative approaches that draw from behavioral economics, narratives, advertising and public health. The core's approach uses a highly collaborative administrative structure and processes so that it is well-integrated with the other Penn ADCC cores. Jason Karlawish, the core leader, is the co-associate director of the ADCC, associate director of and a researcher in the Clinical Core, and co-leader of the Research Education Component. Moreover, the Outreach and Recruitment and Clinical Cores share key staff dedicated to outreach to the African-American community. Our mission driven approach follows two overall strategies. First, each activity has an explicit statement of how it fulfills outreach, recruitment or retention, or educational efforts, with some activities fulfilling several of these efforts. Second, the more resources, such as time and effort that we expend on an activity, the more important it is to have measurements in place to assess outcomes.

Agency
National Institute of Health (NIH)
Institute
National Institute on Aging (NIA)
Type
Center Core Grants (P30)
Project #
5P30AG010124-28
Application #
9519737
Study Section
Special Emphasis Panel (ZAG1)
Project Start
Project End
Budget Start
2018-07-01
Budget End
2019-06-30
Support Year
28
Fiscal Year
2018
Total Cost
Indirect Cost
Name
University of Pennsylvania
Department
Type
DUNS #
042250712
City
Philadelphia
State
PA
Country
United States
Zip Code
19104
Goldman, Jennifer G; Andrews, Howard; Amara, Amy et al. (2018) Cerebrospinal fluid, plasma, and saliva in the BioFIND study: Relationships among biomarkers and Parkinson's disease Features. Mov Disord 33:282-288
Lin, Ming; Gong, Pinghua; Yang, Tao et al. (2018) Big Data Analytical Approaches to the NACC Dataset: Aiding Preclinical Trial Enrichment. Alzheimer Dis Assoc Disord 32:18-27
Jansen, Willemijn J; Ossenkoppele, Rik; Tijms, Betty M et al. (2018) Association of Cerebral Amyloid-? Aggregation With Cognitive Functioning in Persons Without Dementia. JAMA Psychiatry 75:84-95
Stites, Shana D; Rubright, Jonathan D; Karlawish, Jason (2018) What features of stigma do the public most commonly attribute to Alzheimer's disease dementia? Results of a survey of the U.S. general public. Alzheimers Dement 14:925-932
Seo, Sang Won; Thibodeau, Marie-Pierre; Perry, David C et al. (2018) Early vs late age at onset frontotemporal dementia and frontotemporal lobar degeneration. Neurology 90:e1047-e1056
Shi, Min; Tang, Lu; Toledo, Jon B et al. (2018) Cerebrospinal fluid ?-synuclein contributes to the differential diagnosis of Alzheimer's disease. Alzheimers Dement 14:1052-1062
Wang, Qi; Guo, Lei; Thompson, Paul M et al. (2018) The Added Value of Diffusion-Weighted MRI-Derived Structural Connectome in Evaluating Mild Cognitive Impairment: A Multi-Cohort Validation1. J Alzheimers Dis 64:149-169
Kirson, Noam Y; Scott Andrews, J; Desai, Urvi et al. (2018) Patient Characteristics and Outcomes Associated with Receiving an Earlier Versus Later Diagnosis of Probable Alzheimer's Disease. J Alzheimers Dis 61:295-307
Barnes, Josephine; Bartlett, Jonathan W; Wolk, David A et al. (2018) Disease Course Varies According to Age and Symptom Length in Alzheimer's Disease. J Alzheimers Dis 64:631-642
Zee, Jarcy; Xie, Sharon X (2018) The Kaplan-Meier Method for Estimating and Comparing Proportions in a Randomized Controlled Trial with Dropouts. Biostat Epidemiol 2:23-33

Showing the most recent 10 out of 720 publications